Psychiatry for Practice, 2017, issue 2

Editorial

Online závislosti: Příspěvek ke zmírnění paniky

Mgr. Kateřina ©kařupová, Ph.D.

Psychiatr. praxi 2017; 18(2)  

Review articles

Current and potential pharmaceutical possibilities in PTSD treatment

MUDr. Petra Havlíková

Psychiatr. praxi 2017; 18(2): 56-58 | DOI: 10.36290/psy.2017.010  

Posttraumatic stress disorder (PTSD) is a prolonged or delayed response of an individual to life-threatening situations. The disease often has a chronic progression and negatively affects the quality of the patients’ life. The article offers a review of currently used psychopharmaceuticals as well as potentially potent pharmaceuticals, which has not been recommended in clinical practice so far. Psychotherapeutic approaches that form an integral part of PTSD therapy go beyond the overview and attention to them will be paid elsewhere.

Treatment of depressive disorder with cognitive dysfunction

prof. MUDr. Eva Čeąková, CSc.

Psychiatr. praxi 2017; 18(2): 60-63 | DOI: 10.36290/psy.2017.011  

Cognitive dysfunction frequently occurs in acute depression and can persist into remission. Cognitive impairments impacts on patient functioning and negatively influence ability to perform adequately at work. As evidenced by the results of numerous studies drugs with anticholinergic effect (e. g. tricyclic antidepressants) may adversly affect cognitive functions. The most frequently prescribed antidepressants, selective serotonin reuptake inhibitors may improve cognitivy dysfunction in depression. Agent also including a noradrenergic component such as selective serotonin and noradrenaline reuptak inhibitorts appears to be more effective in respect...

Mirtazapine in clinical practice

MUDr. Sylva Racková, Ph.D.

Psychiatr. praxi 2017; 18(2): 64-68 | DOI: 10.36290/psy.2017.012  

Summary: Mirtazapine belongs to antidepressants with a dual mechanism of action (NaSSAs), influencing serotonergic and noradrenergic neurotransmission. It is an antidepressant with a high efficacy in the treatment of depression. The efficacy of mirtazapine is comparable with or higher than that of other antidepressants. It is different in the onset of action and in the profile of adverse events. The aim of this article is to provide more information about this antidepressant and describe the type of patients who are suitable for this medication.

Possibilities of psychosocial rehabilitation in long term inpatient care

MUDr. Marek Páv, Ph.D., Bc. Jana Pluhaříková Pomajzlová, MUDr. Jana ©»astná

Psychiatr. praxi 2017; 18(2): 69-74 | DOI: 10.36290/psy.2017.013  

The process of psychosocial rehabilitation helps people with mental health problems increase their quality of life and may have important role in the personal recovery process. It stands on supporting of strengths and sources of support, there is a major work with the environment with the goal to maximise possibilities of inclusion to the community. Tenets are the principles of recovery and empowerment, help in rebuilding personal identity and finding new meaning of life. It is important to step from wishes and needs perceived by the person him/herself. The person systematically works towards fulfilling his/her needs in major areas of life, setting...

Autism spectrum disorders – part 1

doc. MUDr. Iva Dudová, Ph.D., Mgr. Markéta Mohaplová

Psychiatr. praxi 2017; 18(2): 75-77  

Part 1 of the review article on autism spectrum disorders discusses the new tasks faced by physicians and psychologists who are involved in the diagnostic and therapeutic process in children with these disorders. It informs of the increase in prevalence and provides possible explanations for this epidemiological trend. Current information on the aetiopathogenesis of autism spectrum disorders and on the results of neuroimaging studies is summarised. The association between the development of autism spectrum disorders and vaccination is reported as unconfirmed. The clinical presentation of childhood and atypical autism and of Asperger syndrome is...

Case report

Pregabalin in the treatment of generalized anxiety disorder

MUDr. Martin Hýľa

Psychiatr. praxi 2017; 18(2): 78-80 | DOI: 10.36290/psy.2017.015  

Generalized anxiety disorder is one of the most common anxiety disorders. Pregabalin is unique due to its mechanism of action among other anxiolytics. It´s effectiveness is proven both in acute and long-term phase of treatment. The case report narrates its use in a patient resistant to prescribed antidepressants and further good therapeutic response to pregabalin.

Pathologic sexual aggression in practice

MUDr. Jiří ©varc, Ph.D.

Psychiatr. praxi 2017; 18(2): 81-83 | DOI: 10.36290/psy.2017.016  

In Czech Republic Pathologic sexual aggression is diagnosis for men who committed sexual crime, in order to impose them the in-patient sexologic treatment (mental disorder is required). The author criticizes such concept by case examples: Pathologic sexual aggression is not medical diagnosis. The treatment (corrective program) should be imposed for the sexual crime, not for the mental disorder (whose diagnostic process is disunited). But major opinion among Czech sexologist is different.

Rorschach method as a direct Indicator of the particular drug Choice in patients with affective disorders

Mgr. Vladimír Stuchl

Psychiatr. praxi 2017; 18(2): 84-86 | DOI: 10.36290/psy.2017.041  

Abstract: We are presenting an entirely novel approach to the cooperation framework between the clinical psychologist and psychiatrist. It consists in the diagnostics as well as pharmacotherapeutic decision making based on Rorschach Test in patients with affective disorders. This fact is based on a finding, that the test markers of Rorschach could better predict the treatment response for the particular drug than other mainstream approaches.

At a glance

Vascular dementia

MUDr. Filip Caisberger, doc. MUDr. Martin Valią, Ph.D.

Psychiatr. praxi 2017; 18(2): 87-90  

This article presents a brief practical approach to the diagnosis and treatment of vascular dementia.


Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.